Claims about molecular mechanisms underlying the resistance to anti-hormones of prostate cancer cells find support in biological experiments, which involve hormone-independent activation of the androgen receptor's (AR) transcriptional activity. In order to test this hypothesis, we attempted to shut down the expression of AR by the means of target-directed antisense oligonucleotides. A set of 49 oligonucleotides matching sequences of the AR mRNA either in the coding sequence or in the 3 0 and 5 0 untranslated regions were synthesized and examined in a cellular AR-dependent reporter system. Five antisense oligonucleotides were identified as highly potent inhibitors of AR-driven gene expression in a cellular reporter assay. These five were further profiled using point-mutated control sequences for the assessment of AR inhibition. In addition the expression of another AR-driven gene, the modulator of PSA expression (gene for inhibition of prostate specific antigen, an endogenous, AR-driven gene) was examined. Finally, we observed that the hormone-independent but AR-mediated transactivation by IGF-1 could also be specifically shut-down by these antisense oligonucleotides. The selection of highly target-restricted antisense oligonucleotides in the prostate cancer cell line LNCaP provided tools to study a central role of the androgen receptor in growth regulation of prostatic cancer cell lines and could be of utility in cancer situations in vivo.
Introduction
One of the critical tissue-specific growth factors involved in regulating the cellular composition of the normal prostate is the hormone androgen. Its function is based on an induction of the transcriptional activity for a protein that serves as its receptor: the androgen receptor (AR); in addition, androgen acts on a set of specific genes, which themselves have an impact on either the rate of cell proliferation or cell death. 1 As prostatic cancers, as well as the normal prostate, often retain a comparable responsiveness to androgenic regulation of their rate of cell proliferation and=or rate of cell death, most of them are initially responsive to androgen ablation therapy. While 60 -70% of all men with prostatic cancer treated by androgen ablation therapy show at least a partial initial response, the actual clinical benefit of such a therapy is highly variable among individual patients. Moreover, in most, if not all, patients the tumor eventually recurs after changes to a state that is highly resistant to further antiandrogen therapy. 1 Despite the development of various hypothetical models, the underlying molecular mechanism for this transition is still unclear. Nevertheless, high levels of androgen-regulated genes products such as prostate specific antigen (PSA) detected in hormoneinsensitive prostate tumors cells support the idea that the signaling pathway involving the androgen receptor (AR) may still be intact but is possibly activated in an androgen-independent manner. 2 To date, four main hypotheses have been developed to understand how the androgen signal transduction pathway could mediate androgen-independent tumor progression: an insaturable overexpression of the wild-type androgen receptor gene, 3 constitutive androgen-receptor gene mutations, 4, 5 excessive recruitment of transcriptional coactivators such as ARA, 6 or alterations in the cross-talk between the androgen receptor and the growth factor receptor pathway. 7 Of note is that none of these hypotheses invokes the loss of AR expression, and in each one of them, AR continues to play a pivotal role. In order to provide a tool for examining the hypothesized models, we aimed at achieving a selective suppression of AR expression in the hormoneindependent prostatic model cell line LNCaP 8 by use of target-specific and selective synthetic antisense oligonucleotides.
Materials and methods

Isolation of a minimal Probasin (Pb)-promoter
The 271bp DNA for Pb-promoter was PCR amplified from genomic DNA extracted from the rat cell line RBA-CT9 using the Wizard 1 genomic DNA purification system from Promega according to the manufacturer's instructions. Polymerase chain reactions (PCR) were performed in a total volume of 100 ml with 1 ng of genomic DNA, 0.8 mM dNTPs, specific primers, and Clontech's Advantage KlenTaq polymerase according to the manufacturer's instructions. The following primer pairs containing engineered restriction sites were used: upstream primer: 5 0 -GCTCTAGAATATGATAGCATCTTGTTCT-3 0 downstream primer: 5 0 -GCGGATCCTCTGGACCTCACT-GACAAG-3 0 ; (underlined nucleotides correspond to promoter sequences). PCRs were performed in a thermal cycler (MJ Research, model PTC-200) using the following conditions: after heating the reaction for 1 min at 94 C, PCR was performed at 92 C, 30 s, followed by annealing at 55 C, 1 min, and extension at 68 C, 1 min for 30 cycles, and a final extension at 68 C for 3 min.
Construction of reporter plasmid
The resulting PCR products were restriction endonucleasedigested (XbaI-BamHI), isolated from a 1% agarose gel and purified using the Qiaex II kit according to the manufacturer's protocol (Qiagen, Hilden, Germany). DNA was subsequently ligated into the pGL3-basic vector, cut with XbaI-BglII. These DNAs were used to transform E. coli DH5a (BRL, Life Technologies). Nucleotide sequences of promoters were confirmed using ABI prism dye terminator cycle sequencing with pGL3 specific primers, on an ABI model 377 DNA sequencer (Applied Biosystems).
Cell culture and transfections
LNCaP cells were cultured in RPMI medium supplemented with glutamine (1%), FCS (10%), and Pen=Strep (1%). Fourty-eight hours prior to transfection, cells were seeded into six-well dishes (area per well 3 cm 2 ) at 3 6 10 5 cells per well in dextran-charcoal stripped media. Cells were transfected using liposome-mediated transfection (Effectene, Qiagen). After 6 h of incubation, 1 ml of fresh charcoal-stripped medium was added with or without synthetic hormone R1881 (NEN, Dupont) at a final concentration of 100 nM. After another 48 h culture period at 37 C cells were harvested, lysed and assayed for luciferase activity.
Results
Isolation of probasin promoter and optimization of reporter assay
The rat probasin (Pb)-encoding gene encodes an androgenregulated protein specific to the dorsolateral epithelium. 9 -11 Isolation of the Pb gene has facilitated the identification of cis-acting androgen response regions within the 5 0 flanking region. 12 As we sought to use an androgen-responsive promoter as a read-out for the regulation of AR-expression by antisense oligonucleotides, we isolated the 5 0 flanking region of the probasin gene from a genomic rat library using PCR with two specific primers chosen within the sequence published by Rennie et al. 12 This minimal promoter was cloned into the luciferase reporter system pGL3-basic (promega) to yield the reporter plasmid PbminLuc. Activity of the probasin promoter was tested and optimized in transient transfection assays under variation of parameters concerning hormone concentration and time of hormonal induction (results not shown). In order to maintain optimal conditions to measure the dynamics of the AR-response in LNCaP, we exclusively used the following, optimized parameters for all our antisense studies: amount of reporter PbMinLuc: 0.4 mg=5 6 10 5 cells, concentration of the synthetic hormone R1881: 100 nM, time for hormonal induction after transfection: 6 h, and harvesting time after hormone induction: 48 h.
Screening of anti-AR antisense oligonucleotides
Based on a theoretical scan for suspected target areas suitable for antisense intervention (B Cuenoud, personal communication) a comprehensive series of 47 different oligonucleotides of two different sizes, either 15-mers or 20-mers in length, (see Table 1 ) was synthesized containing two different formats: either phospohorothioate (PS)=2 0 Methyl-O-Ethyl (MOE) 'hemi-mers' or MOE-PS-MOE 'gap-mers', as indicated in Table 1 . Sequences of the different oligonucleotides correspond to the antisense sequence of the AR gene either in the 5 0 untranslated region (oligo numbers 1 -7), including the start codon of AR (oligo numbers 8 and 9), or within the AR-coding sequence (oligo numbers 10 -46), or within the 3 0 untranslated region of the human AR mRNA (oligo number 47) ( Figure 1 , panel A; and Table 1 ). The 47 antisense oligonucleotides were initially screened at a single concentration of 100 nM for inhibition of recombinant, androgen-receptor controlled expression of luciferase (cotransfection with PbminLuc). Resulting activities from three independent experiments were averaged, calculated as x-fold repression of the control luciferase activity (R1881 induction in absence of oligonucleotide), and reported in the histogram of Figure 1 , panel B. From this first screening five antisense oligonucleotides were selected, which repressed AR-driven gene expression above an arbitrary threshold of 40-fold (histogram Figure 1 , panel B). Two of these five oligonucleotides corresponded to sequences located within the 5 0 -untranslated region of AR mRNA (oligo numbers 2 and 3), the other three map to coding sequences for the N-terminal domain of AR (oligo numbers 10, 12 and 31, bold numbers in Figure 1 , Panel A). Interestingly, these latter positions fall into a known region, which has the lowest degree of conservation among various nuclear receptors. 13 
Activity profiling of selected antisense oligonucleotides
Using the same standardized conditions the five selected antisense oligonucleotides were then further assessed for interference with AR-mediated gene activation. The ARdriven luciferase reporter was used to study the oligonucleotides at various concentrations. Results were averaged from five independent experiments and are 
Specificity towards the transcriptional target
The same concentrations of oligonucleotides were applied in a control assay to interrogate specificity for a defined transcriptional pathway. Antisense oligonucleotides were co-transfected with a plasmid, which expresses luciferase activity under the control of a constitutive CMV promoter (pGL3control, lower panel). Addition of the androgen agonist R1881 did not result in any significant enhancement of the constitutive expression (compare lanes '7H' and ' þ R1881'), and none of the oligonucleotides was able to inhibit the constitutive luc expression to a significant extent. These results support the specificity of the oligonucleotides towards androgen-driven expression. Readings corresponding to the oligonucleotide concentration that reduced AR-driven gene expression by 50% were graphically determined and summarized as IC 50 values in Table 2 . The five superior oligonucleotides 2, 3, 10, 12 and 31 were then resynthesized with a homogeneous phosphorothioate backbone between all bases (full P ¼ S) and tested in the androgen-driven reporter assay. The corresponding IC 50 values, as reported in Table 2 , indicate that the different chemistry did not have a major impact on the potency of the antisense molecules. Moreover, since the additional thioate-links did not increase activity, it can be assumed that the length of the P ¼ S window in hemiand gapmer was sufficient for full RNase H activity. Elimination of the MOE-moiety on the other hand also indicated that post-transcriptional components had no major contribution to the molecules' activity.
Target sequence selectivity of antisense molecules
In a subsequent step the sequence-specificity of the selected antisense molecules was verified by introducing specific mismatches at three position in each oligonucleotide (bold bases in Table 2 ). These mismatched oligos were tested in the androgen-driven reporter assay and for each of these, IC 50 values were calculated and reported in Anti-AR antisense in LNCaP F Hamy et al Table 2 . The resulting activities clearly indicated a high specificity of the perfectly matching oligo sequences since an introduction of three-mismatched bases severely impaired the activity of the five antisense molecules (minimum selectivity index ¼ 24.5 for oligo number 10).
Effects of antisense oligonucleotides on AR levels
Oligonucleotide number 31 was then sub-selected as most active candidate with the most favorable activity= selectivity profile. We tested its antisense-mediated suppressive activity on its direct target, the androgen receptor. Oligo 31 was applied to LNCaP cells in the presence of an uptake facilitator. After 48 h incubation time at 37 C total cell lysates were prepared and separated by denaturing polyacrylamide gel electrophoresis. Total levels of AR were detected by immunoblotting with an AR-specific antibody (Figure 3) . Results show that in the presence of as little as 1nM specific antisense oligonucleotide, such as number 31, levels of AR became undetectable, whereas the 117 Kd band corresponding to AR was still detected at concentrations of 100 nM of the corresponding mismatched oligonucleotide.
Inhibition of endogenous androgen-driven gene
Prostate specific antigen (PSA) is a known indicator of prostatic cells activity. This protein is used as a serodiagnostic marker for patients suffering from prostate cancer. 14 PSA has been clearly demonstrated to belong to the genes that are tightly under the control of androgens and the androgen receptor. Like in the case of the probasin gene, androgen response elements have also been identified in the PSA-promoter. 15 Figure 3 shows an immunoblot of LNCaP cells treated with various concentrations of oligo 31 or its mismatch. The induction of PSA expression becomes clearly visible upon addition of hormone (Lanes '7R1881' and ' þ R1881'). This androgen-induced expression can be dose-dependently inhibited with the addition of increasing concentrations of oligo 31 to the culture. A similar extent of inhibition could not be reached with any of the mismatched oligonucleotides, even when higher concentrations were used.
Hormone-independent AR-activation by IGF-1
The stimulation of AR-mediated gene transcription by growth factors such as IGF-1 in absence of any hormonal stimulation has been reported. 7 As this effect had been shown to still depend on the presence of a functional AR, we tested oligonucleotide 31 and its corresponding mismatch sequence for inhibition of such a hormoneindependent IGF-1=AR gene activation. A three-fold stimulation of AR-mediated luciferase expression could be observed upon addition of 100 ng=ml of IGF-1 to LNCaP cells transfected with PbminLucNeo. Although 'modest', this effect is comparable to the one observed for IGF-1 on the induction of the endogenous PSA in LNCaP cells. 7 In order to have a read-out with a sufficient dynamic range, we arbitrarily set this induction level to 100% and then assesses any effect of antisense oligonucleotides. Results are reported in Figure 4 and unambiguously show that oligo 31 was able to dose-dependently inhibit IGF-1=AR-mediated gene induction. Such a dosedependence was not observed after treatment with the mismatched oligonucleotide.
Discussion
In addition to serving as potential candidates for drug intervention on a specific target gene, antisense molecules have proven to be useful tools in cellular systems in vitro to study the biological role of a given gene product. 16 Our Anti-AR antisense in LNCaP F Hamy et al study confirms not only the expected: that not all oligonucleotides function equally well as specific, nucleic acid targeting sequences for antisense-driven gene inhibition. It also demonstrates that even after stringent exclusion of those oligonucleotides that contain specific sequence motifs such as G-quartets, G=C-runs, or short repeat stretches, highly active and target-specific oligonucleotides can be identified. For many motif-driven molecules additional activities have been reported. 17 The ARspecific oligonucleotide sequence were selected by two ways, either based on their G=C content and their sequence uniqueness vs available databases of expressed human genes (20 mers); or by a more rational approach using arrays which probes the in vitro accessibility of the target. 18 Our results show that both approaches can yield antisense molecules with similar potency. It remains to be determined why some oligonucleotides from the first series mapped to regions of the mRNA that the in vitro array-technique had defined as 'non accessible'. 18 In agreement with the literature, our data also suggest that, beyond a certain number, the length of an antisense oligonucleotide does not seem to influence specificity and amplitude of activity; that is, the cellular activity was generally found to be quite similar for 15 mers and 20 mers, as was the selectivity index determined for an oligonucleotide vs its respective mismatch. Another central observation concerned the phosphate backbone modification. Presence of thioate-links was critical, which hints at the need for RNase H activity as the underlying mechanism of activity. The position of a P ¼ S 'window' within the oligonucleotide was not critical (same activity of hemi-versus gapmer), and the utilized length was sufficient for full activity (full length P ¼ S had no increased inhibitory activity). Moreover, the removal of 2 0 -modifications, such as 2 0 MOE, did not significantly alter the oligonucleotide's activity, and we conclude that a contribution through translational mechanisms is unlikely. The final, selected oligonucleotide proved to be inhibitory for the expression of AR function which correlated with a potent and selective inhibition of androgen-driven gene activation. More importantly, our antisense tool strongly suggests that even the hormone-independent activation of androgen-targeted genes is still mediated by the androgen receptor (and not by alternative, AR-suspending pathways).
Two recent, related studies using antisense oligonucleotides against particular sequences of the AR in the same cellular system LNCaP cells showed that a targeted decrease of AR protein levels occurred together with an antiproliferative effect. 19, 20 This study did not report any details of antisense activity on a constitutive promoter. The two antisense molecules used in this study affected two very peculiar stretches in the AR sequence: the socalled CAG-repeat and a CGG-repeat. In contrast to our results, these two sequences are not at all unique for the AR gene. A BLAST search against the public database (Genbank) revealed a high homology to various sequences also found in genes for other critical proteins: beside the AR cDNA, the CAG repeat as a perfect match (15=15) is found in 11 additional human mRNAs; the CGG repeat matches (15=15) with 56 other gene products (some of which are central to cell growth and proliferation). In contrast, amongst our five selected oligonucleotides none had more than one matching hit. Only number 31, the most selective for AR vs our control, the CMVpromoter, had one additional perfect match (Genbank accession number AL121826), < 6 kb upstream from the open reading frame of a putative uncharacterized gene.
In summary, our data show that, through the systematic synthesis of a series of oligonucleotides, we could identify several antisense molecules that possess a highly specific inhibitory potential on AR-driven gene expression in a hormone-insensitive cellular system, and they are active on hormone-induced and uninduced ARdependent genes. As AR function is found in vivo in many instances of androgen-insensitive prostatic tumor cells and even in metastases, our study may have implications for prostate cancer and therapy.
